Tag: 1

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

A clinical trial testing the toxicity of a KRAS inhibitor demonstrated early promising antitumor activity and few adverse side effects in patients with advanced non-small cell lung cancer harboring KRAS G12C mutation, according to research presented today at the IASLC 2019 World Conference on Lung Cancer, hosted by the International Association for the Study of

Who are the 1 in 4 American women who choose abortion?

The abortion debate is at the center of U.S. political dialog. Voices from both sides flood social media feeds, newspapers, radio and television programs. In the last year, attacks on reproductive rights sharply increased. In 2019, Georgia, Missouri, Ohio, Kentucky and Mississippi successfully passed so-called “heartbeat” bans to prohibit abortion as early as six to

Ebola epidemic in DR Congo now exceeds 1,000 cases

Ebola virus particles (red) on a larger cell. Credit: NIAID The number of cases in a nearly eight-month-old epidemic of Ebola in eastern DR Congo now exceeds 1,000, almost two-thirds of whom have died, the health ministry said late Sunday. “The accumulated number of cases is 1,009,” of which 629 cases were fatal, it said.

New way to prevent heart disease in type 1 diabetes

Scientists reveal the mechanism which allows a commonly prescribed drug for type 2 diabetes to prevent heart disease in patients with type 1 diabetes–and could lead to new treatments. Metformin is an inexpensive treatment that is often used for type 2 diabetes to lower blood sugar levels by reducing glucose production in the liver. The

Joslin researchers report excessive fetal growth despite well-controlled type 1 diabetes

A new study has shown that despite excellent glycemic control and low glycemic variability throughout their pregnancies, women with type 1 diabetes tended to give birth to infants who were large for gestational age. Researchers documented elevated fetal weight and abdominal circumference percentages throughout the pregnancies that were consistent with accelerated prenatal growth, as documented

Stigma adds to burden of type 1 diabetes

(HealthDay)—Michael Wright was just 16 when he was diagnosed with type 1 diabetes, and although his friends supported him, he always felt different. “I would do my injections and testing in private [in another room or even the bathroom] to avoid having conversations about diabetes with people,” he said. It was also to avoid stares